137 related articles for article (PubMed ID: 38238615)
1. Avoiding lead-time bias by estimating stage-specific proportions of cancer and non-cancer deaths.
Chang ET; Clarke CA; Colditz GA; Kurian AW; Hubbell E
Cancer Causes Control; 2024 May; 35(5):849-864. PubMed ID: 38238615
[TBL] [Abstract][Full Text] [Related]
2. Projected Reductions in Absolute Cancer-Related Deaths from Diagnosing Cancers Before Metastasis, 2006-2015.
Clarke CA; Hubbell E; Kurian AW; Colditz GA; Hartman AR; Gomez SL
Cancer Epidemiol Biomarkers Prev; 2020 May; 29(5):895-902. PubMed ID: 32229577
[TBL] [Abstract][Full Text] [Related]
3. Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics.
Cronin KA; Lake AJ; Scott S; Sherman RL; Noone AM; Howlader N; Henley SJ; Anderson RN; Firth AU; Ma J; Kohler BA; Jemal A
Cancer; 2018 Jul; 124(13):2785-2800. PubMed ID: 29786848
[TBL] [Abstract][Full Text] [Related]
4. 20-Year Comparative Survival and Mortality of Cancer of the Stomach by Age, Sex, Race, Stage, Grade, Cohort Entry Time-Period, Disease Duration & Selected ICD-O-3 Oncologic Phenotypes:
Milano AF
J Insur Med; 2019; 48(1):5-23. PubMed ID: 31609640
[No Abstract] [Full Text] [Related]
5. Non-bladder cancer mortality in patients with urothelial cancer of the bladder.
Scosyrev E; Wu G; Golijanin D; Messing E
Urol Oncol; 2013 Jul; 31(5):656-63. PubMed ID: 21550827
[TBL] [Abstract][Full Text] [Related]
6. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study.
Clegg LX; Reichman ME; Miller BA; Hankey BF; Singh GK; Lin YD; Goodman MT; Lynch CF; Schwartz SM; Chen VW; Bernstein L; Gomez SL; Graff JJ; Lin CC; Johnson NJ; Edwards BK
Cancer Causes Control; 2009 May; 20(4):417-35. PubMed ID: 19002764
[TBL] [Abstract][Full Text] [Related]
7. Assessing the utility of cancer-registry-processed cause of death in calculating cancer-specific survival.
Hu CY; Xing Y; Cormier JN; Chang GJ
Cancer; 2013 May; 119(10):1900-7. PubMed ID: 23408226
[TBL] [Abstract][Full Text] [Related]
8. Mammography use, breast cancer stage at diagnosis, and survival among older women.
McCarthy EP; Burns RB; Freund KM; Ash AS; Shwartz M; Marwill SL; Moskowitz MA
J Am Geriatr Soc; 2000 Oct; 48(10):1226-33. PubMed ID: 11037009
[TBL] [Abstract][Full Text] [Related]
9. Cancer stage at diagnosis and survival among persons with Social Security Disability Insurance on Medicare.
McCarthy EP; Ngo LH; Chirikos TN; Roetzheim RG; Li D; Drews RE; Iezzoni LI
Health Serv Res; 2007 Apr; 42(2):611-28. PubMed ID: 17362209
[TBL] [Abstract][Full Text] [Related]
10. Has the Affordable Care Act Been Associated with Increased Insurance Coverage and Early-stage Diagnoses of Bone and Soft-tissue Sarcomas in Adults?
Malik AT; Alexander J; Khan SN; Scharschmidt TJ
Clin Orthop Relat Res; 2021 Mar; 479(3):493-502. PubMed ID: 32805094
[TBL] [Abstract][Full Text] [Related]
11. Cancer surveillance series: interpreting trends in prostate cancer--part II: Cause of death misclassification and the recent rise and fall in prostate cancer mortality.
Feuer EJ; Merrill RM; Hankey BF
J Natl Cancer Inst; 1999 Jun; 91(12):1025-32. PubMed ID: 10379965
[TBL] [Abstract][Full Text] [Related]
12. Medicare payments from diagnosis to death for elderly cancer patients by stage at diagnosis.
Riley GF; Potosky AL; Lubitz JD; Kessler LG
Med Care; 1995 Aug; 33(8):828-41. PubMed ID: 7637404
[TBL] [Abstract][Full Text] [Related]
13. Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older.
Yancik R; Wesley MN; Ries LA; Havlik RJ; Edwards BK; Yates JW
JAMA; 2001 Feb; 285(7):885-92. PubMed ID: 11180731
[TBL] [Abstract][Full Text] [Related]
14. Association of computed tomography screening with lung cancer stage shift and survival in the United States: quasi-experimental study.
Potter AL; Rosenstein AL; Kiang MV; Shah SA; Gaissert HA; Chang DC; Fintelmann FJ; Yang CJ
BMJ; 2022 Mar; 376():e069008. PubMed ID: 35354556
[TBL] [Abstract][Full Text] [Related]
15. Estimating lead-time bias in lung cancer diagnosis of patients with previous cancers.
Ge Z; Heitjan DF; Gerber DE; Xuan L; Pruitt SL
Stat Med; 2018 Jul; 37(16):2516-2529. PubMed ID: 29687467
[TBL] [Abstract][Full Text] [Related]
16. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer.
Edwards BK; Noone AM; Mariotto AB; Simard EP; Boscoe FP; Henley SJ; Jemal A; Cho H; Anderson RN; Kohler BA; Eheman CR; Ward EM
Cancer; 2014 May; 120(9):1290-314. PubMed ID: 24343171
[TBL] [Abstract][Full Text] [Related]
17. Direct economic burden of high-risk and metastatic melanoma in the elderly: evidence from the SEER-Medicare linked database.
Davis KL; Mitra D; Kotapati S; Ibrahim R; Wolchok JD
Appl Health Econ Health Policy; 2009; 7(1):31-41. PubMed ID: 19558193
[TBL] [Abstract][Full Text] [Related]
18. Causes of death among cancer patients.
Zaorsky NG; Churilla TM; Egleston BL; Fisher SG; Ridge JA; Horwitz EM; Meyer JE
Ann Oncol; 2017 Feb; 28(2):400-407. PubMed ID: 27831506
[TBL] [Abstract][Full Text] [Related]
19. Assessing non-cancer-related health status of US cancer patients: other-cause survival and comorbidity prevalence.
Cho H; Mariotto AB; Mann BS; Klabunde CN; Feuer EJ
Am J Epidemiol; 2013 Aug; 178(3):339-49. PubMed ID: 23825168
[TBL] [Abstract][Full Text] [Related]
20. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma.
Kato I; Booza J; Quarshie WO; Schwartz K
J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
